| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $5.15 ▼ -0.71% | Yesterday | $5.21 ▲ +0.30% | Tomorrow's Intensity Therapeutics Inc. Common stock (INTS) setup is anchored to $5.19 and targets $5.15 (-0.71%). The near-term read is downside; watch $5.35 / $5.03 because daily realized volatility is about 3.65%. |
Tomorrow's Intensity Therapeutics Inc. Common stock (INTS) setup is anchored to $5.19 and targets $5.15 (-0.71%). The near-term read is downside; watch $5.35 / $5.03 because daily realized volatility is about 3.65%. | ||||
| Week | $5.08 ▼ -2.20% | Last Week | $5.24 ▲ +0.92% | The 7-day Intensity Therapeutics Inc. Common stock model moves from $5.24 to $5.08 (-2.20%). It gives downside momentum context for this stock, so breaks around $5.35 / $5.03 matter more than a single tick. |
The 7-day Intensity Therapeutics Inc. Common stock model moves from $5.24 to $5.08 (-2.20%). It gives downside momentum context for this stock, so breaks around $5.35 / $5.03 matter more than a single tick. | ||||
| Month | $4.95 ▼ -4.69% | Last Month | $5.29 ▲ +1.97% | The 1-month Intensity Therapeutics Inc. Common stock target is $4.95 (-4.69%), compared with the live reference near $5.19. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Intensity Therapeutics Inc. Common stock target is $4.95 (-4.69%), compared with the live reference near $5.19. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $4.75 ▼ -8.41% | Last Year | $5.37 ▲ +3.53% | The 1-year Intensity Therapeutics Inc. Common stock scenario points to $4.75 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Intensity Therapeutics Inc. Common stock scenario points to $4.75 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.30 ▼ -17.14% | 5 Years Ago | $5.56 ▲ +7.20% | The 5-year Intensity Therapeutics Inc. Common stock view is $4.30 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Intensity Therapeutics Inc. Common stock view is $4.30 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $5.19 | Mid |
| Daily Change | -0.48% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 58% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $5.19 | Daily Change | -0.48% |
| Market Cap | $13.19M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.